Pharmarise Holdings, Jun-Feb (Cumulative 3Q) Ordinary Profit Turns to Loss, Dec-Feb Ordinary Profit Turns to Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Mar 25, 2025 12:00 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE Std] announced its financial results at noon (12:00) on March 25th. The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending May 2025 (June 2024 to February 2025) turned into a loss of 18 million yen (compared to a profit of 799 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the March to May period (4Q) is expected to surge 4.7 times that of the same period last year, reaching 161 million yen.

In the most recent three-month period, from December to February (3Q), the consolidated ordinary profit/loss turned to a loss of 47 million yen (compared to a profit of 98 million yen in the same period last year). The operating profit/loss margin worsened from 1.1% in the same period last year to -0.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jun - Feb, 2022	38,730	896	890	208	22.2	62.2	Mar 30, 2023	J-GAAP
Jun - Feb, 2023	40,674	863	799	177	17.2	95.9	Mar 25, 2024	J-GAAP
Jun - Feb, 2024	46,579	95	-18	-272	-24.1	ー	Mar 25, 2025	J-GAAP
YoY	+14.5%	-89.0%	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec - May, 2023	27,518	206	132	-624	-59.4	20	Jun 28, 2024	J-GAAP
Dec - May, 2024 Guidance	34,190	250	114	-101	-8.9	14	Dec 25, 2024	J-GAAP
YoY	+24.2%	+21.4%	-13.6%	+83.8%	+85.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2023	52,030	1,438	1,431	333	35.5	14	Jul 11, 2023	J-GAAP
May, 2024	54,466	916	833	-351	-33.4	20	Jun 28, 2024	J-GAAP
May, 2025 Guidance	64,734	350	143	-214	-18.8	14	Dec 25, 2024	J-GAAP
YoY	+18.9%	-61.8%	-82.8%	+39.0%	+43.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Dec - Feb, 2023	13,726	153	98	-96	-9.3	1.1	Mar 25, 2024	J-GAAP
Mar - May, 2024	13,792	53	34	-528	-50.3	0.4	Jun 28, 2024	J-GAAP
Jun - Aug, 2024	15,231	52	23	-131	-11.7	0.3	Sep 25, 2024	J-GAAP
Sep - Nov, 2024	15,313	48	6	18	1.6	0.3	Dec 25, 2024	J-GAAP
Dec - Feb, 2024	16,035	-5	-47	-159	-14.1	0.0	Mar 25, 2025	J-GAAP
YoY	+16.8%	－	－	-65.6%	-50.5%